Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for malignant pleural effusion
ISRCTN17030426Phase 4Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Aug 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial in malignant pleural effusion (MPE) and malignant pleural thickening (MPT) comparing Zoledronic acid with Placebo (2 arms). Primary endpoint: Change in gadolinium uptake and washout rate on dynamic contrast enhanced magnetic resonance imaging. Started Aug 2010; status: completed.
02
Drugs
zoledronic acid
03
Conditions
malignant pleural effusion (MPE)malignant pleural thickening (MPT)
Beyond the preview
Go deeper on ISRCTN17030426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17030426.